PanTHERA CryoSolutions Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 9

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $16.8M

PanTHERA CryoSolutions General Information

Description

Developer of a cryopreservation system designed to preserve small molecules used in clinical research and studies. The company designs and manufactures patented ice recrystallization inhibitors for use in the cryopreservation of cells, and tissues that maintain cellular function after extended frozen storage, enabling physicians to use less costly storage and transportation systems for cell therapeutics.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • Canadian Blood Services Building
  • 8249 114 Street
  • Edmonton, Alberta T6G 2R8
  • Canada
Primary Industry
Other Healthcare Services
Other Industries
Other Devices and Supplies
Other Healthcare Technology Systems
Parent Company
Corporate Office
  • Canadian Blood Services Building
  • 8249 114 Street
  • Edmonton, Alberta T6G 2R8
  • Canada

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PanTHERA CryoSolutions Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 04-Apr-2025 $16.8M Completed Generating Revenue
6. Accelerator/Incubator Completed Generating Revenue
5. Grant 07-Jul-2023 Completed Generating Revenue
4. Grant 07-Mar-2023 Completed Generating Revenue
3. Early Stage VC 03-Dec-2020 Completed Generating Revenue
2. Accelerator/Incubator 01-Jan-2019 Completed Startup
1. University Spin-Out 01-Jan-2017 Completed Startup
To view PanTHERA CryoSolutions’s complete valuation and funding history, request access »

PanTHERA CryoSolutions Patents

PanTHERA CryoSolutions Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260146238-A1 Urea-based ice recrystallization inhibitor compounds and compositions, and uses thereof for cryopreservation Pending 27-Nov-2024
WO-2026112740-A1 Urea-based ice recrystallization inhibitor compounds and compositions, and uses thereof for cryopreservation Pending 27-Nov-2024
US-20260146239-A1 Tertiary amide aldonamide based ice recrystallization inhibitor compounds and compositions, and uses thereof for cryopreservation Pending 26-Nov-2024
WO-2026112736-A1 Tertiary amide aldonamide based ice recrystallization inhibitor compounds and compositions, and uses thereof for cryopreservation Pending 26-Nov-2024 C07D205/04

PanTHERA CryoSolutions Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PanTHERA CryoSolutions Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alberta Innovates Other
Casdin Capital Venture Capital Minority
Creative Destruction Lab Accelerator/Incubator
Industrial Biotechnology Innovation Centre Government
National Research Council of Canada Industrial Research Assistance Program Government Minority
You’re viewing 5 of 6 investors. Get the full list »

PanTHERA CryoSolutions FAQs

  • When was PanTHERA CryoSolutions founded?

    PanTHERA CryoSolutions was founded in 2017.

  • Where is PanTHERA CryoSolutions headquartered?

    PanTHERA CryoSolutions is headquartered in Edmonton, Canada.

  • What is the size of PanTHERA CryoSolutions?

    PanTHERA CryoSolutions has 9 total employees.

  • What industry is PanTHERA CryoSolutions in?

    PanTHERA CryoSolutions’s primary industry is Other Healthcare Services.

  • Is PanTHERA CryoSolutions a private or public company?

    PanTHERA CryoSolutions is a Private company.

  • What is the current valuation of PanTHERA CryoSolutions?

    The current valuation of PanTHERA CryoSolutions is .

  • What is PanTHERA CryoSolutions’s current revenue?

    The current revenue for PanTHERA CryoSolutions is .

  • How much funding has PanTHERA CryoSolutions raised over time?

    PanTHERA CryoSolutions has raised $4M.

  • Who are PanTHERA CryoSolutions’s investors?

    Alberta Innovates, Casdin Capital, Creative Destruction Lab, Industrial Biotechnology Innovation Centre, and National Research Council of Canada Industrial Research Assistance Program are 5 of 6 investors who have invested in PanTHERA CryoSolutions.

  • When was PanTHERA CryoSolutions acquired?

    PanTHERA CryoSolutions was acquired on 04-Apr-2025.

  • Who acquired PanTHERA CryoSolutions?

    PanTHERA CryoSolutions was acquired by Biolife Solutions.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process